Related Experiment Videos
A basic treatment equivalent for high-dose-rate gynaecological brachytherapy--a pilot study.
Shalini K Vinod1, Geoff P Delaney, Bin B Jalaludin
1Collaboration for Cancer Outcomes, Research & Evaluation, Liverpool Health Service, Locked Bag 7103, Liverpool BC, NSW 1871, Australia. shalini.vinod@swsahs.nsw.gov.au
Summary
This pilot study identified factors predicting high-dose-rate (HDR) gynaecological brachytherapy duration. A larger study is needed to develop a reliable model for comparing treatment efficiency between centers.
Area of Science:
- Gynaecological oncology
- Radiation oncology
- Medical physics
Background:
- High-dose-rate (HDR) gynaecological brachytherapy is a crucial treatment modality.
- Understanding factors influencing treatment duration is essential for optimizing patient care and resource allocation.
Purpose of the Study:
- To assess factors predicting HDR gynaecological brachytherapy duration.
- To model these factors using Basic Treatment Equivalent (BTE) methodology.
Main Methods:
- Prospective single-arm pilot study involving 20 patients across two centers.
- Recording of patient, tumor, and treatment factors, including brachytherapy component durations.
- Univariate, bivariate analyses, and generalized estimating equations to identify predictive factors and derive a duration prediction model.
Main Results:
- Technique (tandem and ovoids vs. vaginal cylinder), treatment intention (definitive vs. post-operative), plan type (individual vs. standard), hospital, and body mass index were significant predictors of overall brachytherapy duration.
- 53 brachytherapy episodes were analyzed.
Conclusions:
- The study demonstrates the feasibility of using BTE methodology to examine factors influencing gynaecological brachytherapy duration.
- A larger, multicenter study is required to develop a robust predictive model.
- Such a model would enable standardized comparisons of efficiency and treatment capacity across different centers.